2003
DOI: 10.1007/s00701-002-1013-7
|View full text |Cite
|
Sign up to set email alerts
|

Transvenous embolisation of dural carotid-cavernous fistulas by multiple venous routes: a series of 27 cases

Abstract: DCCFs can be successfully treated by transvenous embolisation via different venous routes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
77
0
8

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(88 citation statements)
references
References 28 publications
0
77
0
8
Order By: Relevance
“…If left untreated, the mortality rate is 10.4%, the annual bleeding and the non-hemorrhagic neurological deficit risks are 8.1% and 6.9%, respectively. Therefore, consensus exists, that aggressive-type DAVFs should be treated (2,5,9,18).…”
Section: Discussionmentioning
confidence: 99%
“…If left untreated, the mortality rate is 10.4%, the annual bleeding and the non-hemorrhagic neurological deficit risks are 8.1% and 6.9%, respectively. Therefore, consensus exists, that aggressive-type DAVFs should be treated (2,5,9,18).…”
Section: Discussionmentioning
confidence: 99%
“…En la mayoría de los casos se puede acceder al SC a través del seno petroso inferior, aunque en ocasiones esto no es posible por imposibilidad de canalizarlo o por estar trombosado 12,21,26 . En caso de no poder acceder por dicha vía existen otras alternativas que incluyen el acceso a través del plexo venoso del clivus 7 , el plexo pterigoideo 14 o incluso a través de venas corticales 4 . Sin embargo, estas vías tampoco son siempre practicables endovascularmente.…”
Section: -342unclassified
“…El tratamiento de las FCC indirectas o durales es más complicado, siendo la vía venosa de elección para la mayoría de los autores 1,7,12,18,21,26 . Sin embargo, en ocasiones no es posible el acceso a la FCC por vía venosa transfemoral, siendo necesario un abordaje directo a la vena oftálmica superior (VOS), que fue descrito en 1969 19 y posteriormente utilizado por diferentes autores para el tratamiento de FCC 2,10,15,18,21 .…”
Section: Introductionunclassified
“…CNP may occur due to the fistula or as a complication of endovascular treatment. [1][2][3][4][5][6][7][8][9][10] Periprocedural aggravation or new CNP as well as preinterventional neuro-ophthalmic problems are reported to have a good prognosis. 2 Most previous studies gave an overall rating of the clinical outcome in patients following endovascular treatment of the AVF of the cavernous sinus without reporting the detailed neuro-ophthalmologic findings.…”
mentioning
confidence: 99%